STAT+: HaloMD faces lawsuit alleging No Surprises Act middleman used ‘sham letter,’ misleading data
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Highmark Health filed a June 1 complaint in U.S. District Court for Western Pennsylvania against HaloMD and Bromedicon.
- HaloMD and its client Bromedicon allegedly submitted over 450 ineligible disputes under the No Surprises Act arbitration process.
- The defendants reportedly won more than $3.9 million from Highmark through those disputes.
- Highmark seeks to have the awards vacated and the money returned, calling the scheme a deliberate effort to extract inflated payments.
Why it matters: Highmark could recover $3.9 million and stop future inflated payouts, while HaloMD and Bromedicon face having the awards vacated, returning the money, and incurring legal costs.
